Medicare Enrolled

Dr. Ajay Gaalla, MD

Cardiovascular Disease · Victoria, TX
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
2104 PATTERSON DRIVE, Victoria, TX 77901
3615802200
In practice since 2006 (19 years)
NPI: 1104837772 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gaalla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gaalla? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gaalla

Dr. Ajay Gaalla is a cardiovascular disease in Victoria, TX, with 19 years in practice. Based on federal Medicare data, Dr. Gaalla performed 4,849 Medicare services across 3,631 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gaalla received a total of $8,702 from 29 pharmaceutical and/or device companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gaalla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 17% volume in TX$ $8,702 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,849
Medicare services
Top 17% in TX for cardiovascular disease
3,631
Unique beneficiaries
$149
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~255 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Regadenoson injection (Lexiscan) for heart stress test1,444$43$139
Echocardiogram, transthoracic586$140$566
Office visit, established patient (30-39 min)467$84$257
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician390$49$180
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries351$196$252
Nuclear medicine studies of blood flow in heart muscle at rest and with stress344$1,053$3,106
Electrocardiogram (EKG), 12-lead313$10$50
Office visit, established patient (20-29 min)260$58$174
New patient office visit (30-44 min)220$77$257
Initial hospital admission, high complexity60$132$494
Evaluation of single, dual, multiple lead or leadless pacemaker system53$14$63
Technetium tc-99m sestamibi, diagnostic, per study dose46$43$435
Nuclear medicine study of heart muscle at rest and with stress and spect45$208$812
Initial hospital admission, moderate complexity45$98$335
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes37$9$36
Cardiac catheterization32$160$903
Ultrasound of both sides of head and neck blood flow32$130$544
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional30$19$76
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional30$630$2,030
Ultrasound of heart with probe in esophagus, with report18$81$298
Ultrasound of heart, follow-up16$19$283
Ultrasound of heart blood flow, valves and chambers15$14$53
Ultrasound of heart with color-depicted blood flow, rate and valve function15$2$11
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.5% high complexity
47.2% medium
38.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,702
Total received (2018-2024)
Avg $1,243/year across 7 years
Top 35% in TX for cardiovascular disease
29
Companies
351
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,702 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$839
2023
$841
2022
$799
2021
$616
2020
$408
2019
$1,082
2018
$4,116

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$3,024
Janssen Pharmaceuticals, Inc
$1,023
Novartis Pharmaceuticals Corporation
$713
Boehringer Ingelheim Pharmaceuticals, Inc.
$641
E.R. Squibb & Sons, L.L.C.
$528
Merck Sharp & Dohme LLC
$405
AstraZeneca Pharmaceuticals LP
$400
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$365
Actelion Pharmaceuticals US, Inc.
$314
Amgen Inc.
$190
Merck Sharp & Dohme Corporation
$188
SANOFI-AVENTIS U.S. LLC
$175
Boston Scientific Corporation
$150
Regeneron Healthcare Solutions, Inc.
$84
Lundbeck LLC
$65
Chiesi USA, Inc.
$64
ABIOMED
$53
PFIZER INC.
$52
Allergan Inc.
$51
BIOTRONIK INC.
$41
Edwards Lifesciences Corporation
$32
BOSTON SCIENTIFIC CORPORATION
$29
MEDICOMP INC
$24
ZOLL Circulation Inc
$17
Smith & Nephew, Inc.
$17
Astellas Pharma US Inc
$16
Novo Nordisk Inc
$14
Esperion Therapeutics, Inc.
$14
Cardiovascular Systems Inc.
$13
Top 3 companies account for 54.7% of total payments
Associated products mentioned in payments ›
Assurity Pacemaker · BOSENTAN TABLETS · BRILINTA · BYSTOLIC · Baerveldt Glaucoma Implants · CAMZYOS · CARDIOMEMS · CHANTIX · CLEVIPREX · Cardiac Monitor · CardioMEMS HF System · Confirm Rx · Connectivity and Remote care · Corlanor · DISEASE STATE · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · Ensite Cardiac Mapping System · FARXIGA · Fortify Assura · Impella · JARDIANCE · KENGREAL · LEQVIO · Lexiscan · LifeVest · MITRACLIP · Merlin Connectivity and Remote · Mitra Clip system · NEXLETOL · NORTHERA · OPSUMIT · PICO · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · RESONATE · Repatha · SYNERGY · Temperature Management System · VERQUVO · VIGILANT · WATCHMAN · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $179 per 100 Medicare services performed
Looking for a cardiovascular disease in Victoria?
Compare cardiovascular diseases in the Victoria area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
3
Per 100K population
3.3
County median income
$70,101
Nearest hospital
CITIZENS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gaalla is a cardiac imaging specialist, with above-average Medicare volume (top 17% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gaalla experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Gaalla performed 1,444 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gaalla receive payments from pharmaceutical companies?
Yes. Dr. Gaalla received a total of $8,702 from 29 companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gaalla's costs compare to other cardiovascular diseases in Victoria?
Dr. Gaalla's average Medicare payment per service is $149. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gaalla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →